MZOR Mazor Robotics Ltd. ADS (delisted)

- Recurring Revenue Increases 37% Year-over-Year -

- Solid Momentum Continues into Q2 2017 with Four System Purchase Orders to Date -

- Conference Call Today at 8:30 AM ET (3:30PM IST) -

Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and a leader in the field of surgical guidance systems, reported record first quarter revenue of $11.7 million. As previously announced, the Company received purchase orders for six systems in the 2017 first quarter and ended the quarter with a backlog of 14 systems.

“Our first quarter of 2017 was highlighted by record first quarter revenue and expanded utilization of our Renaissance system installed base,” commented Ori Hadomi, Chief Executive Officer. “Our revenue growth was driven by two factors. First, we supplied 12 Mazor X systems as we continued to process our 2016 year-end backlog. Second, we had record utilization by our installed base during the quarter. The enthusiasm for the Mazor X continues, and to date we have received four purchase orders for the Mazor X in the second quarter of 2017.”

FIRST QUARTER 2017 FINANCIAL RESULTS ON IFRS BASIS ("GAAP")

Revenue for the three months ended March 31, 2017 increased 83% to $11.7 million compared to $6.4 million in the year-ago first quarter. U.S. revenue increased 100% to $11.2 million compared to $5.6 million in the year-ago first quarter, as the Company recognized revenue from 12 Mazor X systems, compared to four Renaissance systems in the 2016 first quarter. The Company ended the quarter with a backlog of 14 Mazor X systems; revenue from these systems is expected to be recorded in 2017. International revenue was $0.5 million compared to $0.8 million in the year-ago first quarter. Recurring revenue from kit sales, services and others increased 37% to $5.2 million in the first quarter of 2017, compared to $3.8 million in the year-ago first quarter. The growth is attributed mainly to the increase of the installed base.

The Company’s gross margin for the three months ended March 31, 2017 was 64.6% compared to 74.2% in the year-ago first quarter. This expected decrease is attributed mainly to discounted pricing to the Company’s Mazor X distribution partner, the higher manufacturing costs of the Mazor X compared to the Renaissance system, and the inclusion of two Renaissance trade-ins to Mazor X. Total operating expenses were $13.3 million compared to $10.0 million in the year-ago first quarter primarily reflecting the Company’s increased investments in sales and marketing activities. Operating loss was $5.7 million compared to an operating loss of $5.2 million in the year-ago first quarter. Net loss for the first quarter of 2017 was $5.2 million, or $0.11 per share, compared to a net loss of $5.1 million, or $0.12 per share, for the year-ago first quarter.

Cash generated by operating activities during the first quarter was $0.7 million compared to $2.9 million cash used in operating activities in the year-ago first quarter. As of March 31, 2017, cash, cash equivalents and investments totaled $63.9 million.

FIRST QUARTER 2017 FINANCIAL RESULTS ON NON-GAAP BASIS

The tables below include reconciliation of the Company’s GAAP results to non-GAAP results. The reconciliation relates to non-cash expenses in the amount of $1.3 million with respect to amortization of intangible assets and to share-based expenses recorded in the first quarter of 2017. On a non-GAAP basis, the net loss in the first quarter of 2017 was $3.9 million, or $0.08 per share, compared to $4.2 million, or $0.10 per share, for the year-ago first quarter.

CONFERENCE CALL INFORMATION

The Company will host a conference call to discuss its first quarter financial results as well as recent corporate developments on May 10, 2017 at 8:30 AM EDT (3:30 PM IDT). Investors within the United States interested in participating are invited to call 888-298-3457. Participants in Israel can use the toll-free dial-in number 1-80-924-5906. All other international participants can use the dial-in number 719-457-2689.

A replay of the event will be available for two weeks following the conclusion of the call. To access the replay, callers in the United States can call 1-866-375-1919 and reference the Replay Access Code: 8737181. All international callers can dial +1-719-457-0820, using the same Replay Access Code. To access the webcast, please visit www.mazorrobotics.com and select ‘Investor Relations.’

Use of Non-GAAP Measures

In addition to disclosing financial results calculated in accordance with generally accepted accounting principles in conformity with International Financial Reporting Standards (GAAP), this press release contains Non-GAAP financial measures for gross profit, operating expenses, operating loss, net loss and basic and diluted earnings per share that exclude the effects of non-cash expense of amortization of intangible assets and share-based expenses. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the Company’s performance that enhances management's and investors' ability to evaluate the Company's net income and earnings per share and to compare them to historical net income and earnings per share.

The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when operating and evaluating the Company’s business internally and therefore decided to make these non-GAAP adjustments available to investors.

About Mazor

Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing through innovation by developing and introducing revolutionary technologies and products aimed at redefining the gold standard of quality care. Mazor Robotics Guidance System enables surgeons to conduct spine and brain procedures in an accurate and secure manner. For more information, please visit www.MazorRobotics.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws. Any statements in this release about future expectations, plans or prospects for the Company, including without limitation, statements regarding the Company’s momentum for 2017, second quarter sales, the amount of and timing of recording of additional revenue from backlog, and other statements containing the words “believes,” “anticipates,” “plans,” “expects,” “will” and similar expressions are forward-looking statements. These statements are only predictions based on Mazor's current expectations and projections about future events. There are important factors that could cause Mazor's actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements. Those factors include, but are not limited to, the impact of general economic conditions, competitive products, product demand and market acceptance risks, reliance on key strategic alliances, fluctuations in operating results, and other factors indicated in Mazor's filings with the Securities and Exchange Commission (SEC) including those discussed under the heading "Risk Factors" in Mazor’s annual report on Form 20-F filed with the SEC on May 1, 2017 and in subsequent filings with the SEC. For more details, refer to Mazor's SEC filings. Mazor undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or to changes in our expectations, except as may be required by law.

    Mazor Robotics Ltd. CONSOLIDATED STATEMENT OF INCOME (in thousands, except per share data)   Three month period ended March 31, 2017     2016 (Unaudited) (Unaudited) Revenue

$

11,719

$

6,419

  Cost of revenue

$

4,149

$

1,654

  Gross profit $

7,570

$ 4,765   Operating costs and expenses: Research and development, net $

1,792

$ 2,131 Selling and marketing $

9,893

$ 6,873 General and administrative $

1,571

$ 983 Total operating costs and expenses $

13,256

$ 9,987   Loss from operations $

(5,686)

$ (5,222)   Financing income, net $

211

$ 175   Loss before taxes on income $

(5,475)

$ (5,047)   Income tax expense (benefit) $

(243)

$ 65         Net loss $

(5,232)

$ (5,112)   Net loss per share - Basic and diluted $

(0.11)

$ (0.12)   Weighted average common shares outstanding - Basic and diluted  

47,750

  42,414           Mazor Robotics Ltd. CONSOLIDATED STATEMENTS OF FINANCIAL POSITION AS OF (U.S. Dollars in thousands)   March 31, December 31, 2017 2016 (Unaudited) (Audited) Current assets Cash and cash equivalents

$

25,896

$

14,954

Short-term investments

32,654

37,862

Trade receivables

3,076

8,225

Other current assets

2,109

1,728

Inventory

5,777

4,715

Total current assets

69,512

67,484

  Non-current assets Long-term investments

5,366

9,017

Property and equipment, net

4,045

3,615

Intangible assets, net

2,176

2,258

Other non-current assets

980

351

Total non-current assets

12,567

15,241

  Total assets

$

82,079

$

82,725

  Current liabilities Trade payables

$

2,314

$

5,018

Deferred revenue

5,879

4,031

Other current liabilities

9,998

8,462

Total current liabilities

18,191

17,511

  Non-current liabilities Employee benefits

403

325

Total non-current liabilities

403

325

  Total liabilities

18,594

17,836

  Equity Share capital

125

124

Share premium

178,252

174,647

Capital reserve for share-based payment transactions

10,081

9,859

Foreign currency translation reserve

2,119

2,119

Accumulated loss

(127,092)

(121,860)

Total equity

63,485

64,889

  Total liabilities and equity

$

82,079

$

82,725

      Mazor Robotics Ltd. CONSOLIDATED CASH FLOW STATEMENTS (U.S. Dollars in thousands)   Three month period ended March 31, 2017     2016 (Unaudited) (Unaudited) Cash flows from operating activities: Loss for the period

$

(5,232)

$

(5,112)

Adjustments: Depreciation and amortization

$

342

$

146

Finance income, net

$

(50)

$

(142)

Share-based payment

$

1,201

$

916 Income tax expense (tax benefit)

$

(243)

$

65

$

1,250

$

985   Change in inventory

$

(1,362)

$ (25) Change in trade and other accounts receivable

$

4,771

$ 1,738 Change in prepaid lease fees

$

(21)

$ (10) Change in trade and other accounts payable

$

1,103

$ (536) Change in employee benefits

$

78

$ 76

$

4,569

$ 1,243   Interest received

$

72

$ 64 Income tax paid

$

-

$ (37)

$

72

$ 27 Net cash provided by (used in) operating activities

$

659

$ (2,857)   Cash flows from investing activities: Proceeds from short-term investments, net

$

8,957

$ 6,646 Investments in long-term investments

$

(98)

$ (496) Purchase of property and equipment

$

(809)

$ (418) Net cash provided by investing activities

$

8,050

$ 5,732   Cash flows from financing activities: Proceeds from exercise of share options and warrants, net

$

- $ 481 Proceeds from exercise of share options by employees

$

2,259

$ 75 Net cash provided by financing activities

$

2,259

$

556   Net increase in cash and cash equivalents

$

10,968

$ 3,431 Cash and cash equivalents at the beginning of the period

$

14,954

$ 13,519 Effect of exchange rate differences on balances of cash and cash equivalents

$

(26)

$ 58 Cash and cash equivalents at the end of the period

$

25,896

$ 17,008 Supplementary cash flows information: Purchase of property and equipment in credit

$

(148)

$ (107) Classification of inventory to fixed assets

$

300

$

-       Mazor Robotics Ltd. RECONCILIATIONS OF GAAP TO NON-GAAP FINANCIAL MEASURES (U.S. Dollars in thousands, except per share data) (UNAUDITED)   Three month period ended March 31, 2017     2016 GAAP gross profit

$

7,570

$ 4,765 Amortization of intangible assets

82

- Share-based payments  

53

  36 Non-GAAP gross profit

$

7,705

$ 4,801 GAAP gross profit as percentage of revenues  

64.6%

  74.2% Non-GAAP gross profit as percentage of revenues

65.7%

74.8%   GAAP operating expenses

$

13,256

$ 9,987 Share-based payments: Research and development

$

158

$ 150 Selling and marketing

$

440

$ 520 General and administrative

$

550

$ 210 Non-GAAP operating expenses

$

12,108

$ 9,107   GAAP operating loss

$

(5,686)

$ (5,222)   Non-GAAP operating loss

$

(4,403)

$ (4,306)   GAAP net loss

$

(5,232)

$ (5,112) Amortization of intangible assets

82

- Share-based payments

$

1,201

$ 916 Non-GAAP net loss

$

(3,949)

$ (4,196)   GAAP basic and diluted loss per share

$

(0.11)

$ (0.12)   Non-GAAP basic and diluted loss per share

$

(0.08)

$ (0.10)  

View source version on businesswire.com: http://www.businesswire.com/news/home/20170510005436/en/

U.S. Contacts:EVC GroupInvestorsMichael Polyviou, 212-850-6020mpolyviou@evcgroup.com;orDoug Sherk, 646-445-4800dsherk@evcgroup.comorFinancial Media ContactTom Gibson, 201-476-0322tom@tomgibsoncommunications.com